With the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs ...

A new white paper from BioDlink, From Complexity to Consistency: How CDMOs Can Unlock One-Step, High-Yield and Homogeneous ...

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

First scalable single-use mixer specifically designed for ADC manufacturing Increases efficiency by 70% compared to stainless steel or glass manufacturing methods Utilizes Ultimus ® Film for superior ...

The antibody-drug conjugate (ADC) manufacturing landscape offers the potential to leverage significant opportunities for cancer treatment, but faces complex challenges. Nevertheless, the ADC market ...

Abzena, a U.K.-based CDMO, will pump $5 million into its Bristol, Pennsylvania, manufacturing site to help meet growing demand for services surrounding antibody-drug conjugates (ADCs) and other ...

Riding high on its Daiichi Sankyo-partnered antibody drug conjugate (ADC) Enhertu—and banking on an approval for its next ADC contender datopotamab deruxtecan this winter—AstraZeneca is placing a big ...

Creative Biolabs provides a one-stop solution from R&D to in vitro evaluation, speeding up ADC projects and satisfying the need for ADC products worldwide. SHIRLEY ...

Ribbon cutting and commissioning of a multipurpose state-of-the-art Antibody-Drug Conjugate (ADC) manufacturing facility that expands capacity by approximately 70-80% Adrian Gillespie, Chief Executive ...

SEOUL, South Korea, April 23, 2025 /PRNewswire/ -- LOTTE BIOLOGICS (CEO James Park) announced on April 24 (KST) that it has signed a manufacturing agreement with an Asia-based biotech company for the ...